Hot Active Runners: Apple Inc (NASDAQ:AAPL), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Pompano Beach, FL -- (SBWIRE) -- 01/09/2013 -- Korean tech titan Samsung Electronics Co is seeking to supply chips to further Chinese and other rising smartphone manufacturers, the chief of its system chip business stated, to defend any fall-off in demand from Apple Inc (NASDAQ:AAPL), which is cutting strings attached to Samsung chips used in its iPhones and iPads.

Korean giant and its top US rival Apple, and largest customer, together account for over half the worldwide smartphone market, and the South Korean titan is the major supplier of mobile processors, or application processors (AP), operating both Apple devices and its personal range of Galaxy phones and tablets.

What Apple is up to after cutting strings with rival-cum-opponent? Find in this report

But, as Apple (AAPL) intends to be less dependable on its opponent for parts for its devices, it is now purchasing lesser Samsung memory chips and display screens as both have gone to fight over patents – doubts have grown that Samsung might see its processor revenues decline.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) again gained investors’ attention by surging above its average volume by higher volume of 15.16 million shares.

At 2:11 AM, the stock was down -3.95% on regular trading session of Wednesday.

How Arena take this investors’ confidence with surging volume? Find in this article

The biotech hot stock is in talks with possible partners in Europe to sell its lately accepted Belviq, the initial new obesity accepted drug in 13 years. The firm is still waiting for the acceptance in Europe. Furthermore, the firm is also seeking for partners in China to grow its market share.

About No Limit Stocks
NOLIMITSTOCKS.com is made up of a team of professional analyst that possess over 30 years of expert, stock market experience. Our goal is to research thousands of companies and provide investors with the latest insights in the market with stocks that can make explosive profits. We study the hottest companies so you don't have to!

Our newsletter is always free to Join and offers a variety of useful investors tools that will help you break the limits! There will be no regrets!

Disclaimer
The assembled information disseminated by nolimitstocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. nolimitstocks.com does expect that investors will buy and sell securities based on information assembled and presented in nolimitstocks.com. PLEASE always do your own due diligence, and consult your financial advisor.